Jeremy Orloff

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Rates of Metformin Use in Stage 3b Chronic Kidney Disease Rose After FDA Label Change”.

Rates of Metformin Use in Stage 3b Chronic Kidney Disease Rose After FDA Label Change

Journal of General Internal Medicine(2021)10.1007/s11606-020-06380-2

N/A

0DataRank · unranked

4 citations

Xian Wu, Jeremy Orloff, Jea Young Min, James Flory, Alex Y. Huang

Prescriber Uncertainty as Opportunity to Improve Care of Type 2 Diabetes with Chronic Kidney Disease: Mixed Methods Study

Journal of General Internal Medicine(2022)10.1007/s11606-022-07838-1

N/A

0DataRank · unranked

9 citations

Dominique Guelce, Crispin Goytia, Jing Li, Jea Young Min, Al Mushlin +3 more

Use of a topical Janus kinase inhibitor in immune checkpoint inhibitor-induced eczematous reaction: a case report

Journal of Dermatological Treatment(2024)10.1080/09546634.2024.2336118

N/A

0DataRank · unranked

10 citations

Hannah Verma, Jeremy Orloff, Austin J. Piontkowski, Amy Tiersten, Angela Lamb +2 more

Risk of lymphoma in patients with atopic dermatitis: A case-control study in the All of Us database

Journal of the American Academy of Dermatology(2024)10.1016/j.jaad.2024.03.038

N/A

0DataRank · unranked

9 citations

Austin J. Piontkowski, Jeremy Orloff, Juliana Pulsinelli, Foysal B. Uddin, Joel Corrêa da Rosa +3 more

Pemphigoid and atopy: A case-control study in the All of Us database

The Journal of Allergy and Clinical Immunology In Practice(2024)10.1016/j.jaip.2024.04.005

N/A

0DataRank · unranked

3 citations

Austin J. Piontkowski, Brandon Block, Jeremy Orloff, Emma Guttman‐Yassky, Nicholas Gulati +1 more